Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Entheon Biomedical Corp. (ENBI.CN)

Entheon Biomedical Corp. (ENBI.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 18,103
  • Shares Outstanding, K 54,039
  • Annual Sales, $ 0 K
  • Annual Income, $ -147 K
  • 60-Month Beta 2.83
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.81
Trade ENBI.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.74
  • Most Recent Earnings -0.04 on 05/31/21
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.320 +3.12%
on 07/28/21
0.430 -23.26%
on 07/06/21
-0.075 (-18.52%)
since 07/05/21
3-Month
0.320 +3.12%
on 07/28/21
0.550 -40.00%
on 06/11/21
-0.180 (-35.29%)
since 05/05/21

Most Recent Stories

More News
Entheon Biomedical Corp. Acquires Lobo Genetics Inc.

Vancouver, British Columbia--(Newsfile Corp. - July 30, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("" or the "") is pleased to announce that the Company completed its acquisition...

ENBI.CN : 0.330 (-1.49%)
ENTBF : 0.2706 (-0.18%)
Entheon Biomedical Further Strengthens Advisory Board with Appointment of Dr. Andy Greenshaw

Vancouver, British Columbia--(Newsfile Corp. - July 28, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("" or the ""), a biotechnology company focused on developing psychedelic...

ENBI.CN : 0.330 (-1.49%)
ENTBF : 0.2706 (-0.18%)
Microdose Is Pleased to Announce the DMT Conference: A Molecular Masterclass

Get a free ticket to the event here:

ENBI.CN : 0.330 (-1.49%)
ENTBF : 0.2706 (-0.18%)
AGN.CN : 0.085 (unch)
Entheon Biomedical Announces Medical Advisor, Dr. Dinesh Bhayana

Vancouver, British Columbia--(Newsfile Corp. - June 30, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("" or the ""), a biotechnology company focused on developing psychedelic...

ENBI.CN : 0.330 (-1.49%)
ENTBF : 0.2706 (-0.18%)
Entheon Subsidiary, HaluGen Life Sciences, Partners with Maya Health to Drive Psychedelics Genetic Test Kit Awareness

Vancouver, British Columbia--(Newsfile Corp. - June 25, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (or the), a biotechnology company focused on developing psychedelic medicines...

ENBI.CN : 0.330 (-1.49%)
ENTBF : 0.2706 (-0.18%)
Entheon Biomedical Subsidiary, HaluGen Life Sciences, Announces Agreement with Third Wave

Vancouver, British Columbia--(Newsfile Corp. - June 22, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon" or the "Company"), a biotechnology company focused on developing...

ENBI.CN : 0.330 (-1.49%)
ENTBF : 0.2706 (-0.18%)
Entheon Biomedical's Wholly-Owned Subsidiary, HaluGen Life Sciences and Silo Wellness Announces Psychedelics Genetic Test Kit Partnership

Vancouver, British Columbia--(Newsfile Corp. - June 17, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (), a biotechnology company focused on developing psychedelic medicines to...

ENBI.CN : 0.330 (-1.49%)
ENTBF : 0.2706 (-0.18%)
SILO.CN : 0.090 (unch)
SILFF : 0.0721 (-19.89%)
Silo Wellness and Entheon Biomedical's Wholly-Owned Subsidiary, HaluGen Life Sciences, Announces Psychedelics Genetic Test Kit Partnership

Silo Wellness Inc. ("Silo Wellness" or "the Company") (CSE: SILO) (FRA: 3K70) (OTC: SILFF), a functional and psilocybin mushroom company offering psychedelic wellness retreats, and Entheon Biomedical Corp....

SILO.CN : 0.090 (unch)
SILFF : 0.0721 (-19.89%)
ENBI.CN : 0.330 (-1.49%)
ENTBF : 0.2706 (-0.18%)
Entheon Biomedical Corp. Announces Agreement to Acquire Lobo Genetics Inc.

Vancouver, British Columbia--(Newsfile Corp. - June 16, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("" or the "") is pleased to announce that the Company has entered into...

ENBI.CN : 0.330 (-1.49%)
ENTBF : 0.2706 (-0.18%)
Entheon Biomedical's Wholly-Owned Subsidiary, HaluGen Life Sciences, Psychedelics Genetic Test Kit Now Available for Sale in US

Vancouver, British Columbia--(Newsfile Corp. - June 10, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon" or the "Company"), a biotechnology company focused on developing...

ENBI.CN : 0.330 (-1.49%)
ENTBF : 0.2706 (-0.18%)

Key Turning Points

3rd Resistance Point 0.343
2nd Resistance Point 0.342
1st Resistance Point 0.338
Last Price 0.330
1st Support Level 0.333
2nd Support Level 0.332
3rd Support Level 0.328

See More

52-Week High 1.350
Fibonacci 61.8% 0.957
Fibonacci 50% 0.835
Fibonacci 38.2% 0.713
Last Price 0.330
52-Week Low 0.320

See More

Business Summary

Entheon Biomedical Corp is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (DMT Products) for the purposes of treating addiction and substance use disorders. Entheon...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar